New‐onset guttate psoriasis secondary to COVID‐19

SARS‐CoV‐2, the virus that causes coronavirus disease 2019 (COVID‐19), is associated with flares of psoriasis in patients with well‐documented disease. Both viral infection and medications used for treatment, like hydroxychloroquine, were incriminated. Herein, we report the case of a 25‐year‐old mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouai, Meriem, Rabhi, Faten, Mansouri, Nada, Jaber, Kahena, Dhaoui, Raouf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319378/
https://www.ncbi.nlm.nih.gov/pubmed/34336212
http://dx.doi.org/10.1002/ccr3.4542
Descripción
Sumario:SARS‐CoV‐2, the virus that causes coronavirus disease 2019 (COVID‐19), is associated with flares of psoriasis in patients with well‐documented disease. Both viral infection and medications used for treatment, like hydroxychloroquine, were incriminated. Herein, we report the case of a 25‐year‐old male patient who presented a first‐onset guttate psoriasis following a COVID‐19 infection. We have not found previous descriptions of de novo guttate psoriasis post‐COVID‐19.

Ejemplares similares